by lythamcorp | Apr 10, 2025 | Healthcare, Shuttle Pharmaceutical News, Shuttle Pharmaceuticals
Filing provisional patent application with the USPTO entitled “PSMA-Targeted PARP Inhibitor conjugates for Precision Cancer Therapy” key to advancement of Diagnostic and Therapeutic programs Dr. Alan Kozikowski, internationally acclaimed pioneer in the...
by lythamcorp | Apr 8, 2025 | Healthcare, ImmuCell Corporation, ImmuCell News
PORTLAND, Maine, April 08, 2025 — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the...
by lythamcorp | Apr 8, 2025 | Consumer, Niagen News
The Company’s flagship patented nicotinamide riboside (NR) ingredient, Niagen®, is manufactured, encapsulated, and bottled in the U.S. and is currently classified as exempt from tariffs, minimizing exposure to tariff-related risks LOS ANGELES – Niagen...
by lythamcorp | Apr 7, 2025 | Industrials, Jewett Cameron, Jewett Cameron News
NORTH PLAINS, Ore., April 07, 2025 — Jewett-Cameron Trading Company Ltd. (“Jewett-Cameron”) (Nasdaq: JCTC), a company committed to innovative products that enrich outdoor spaces, will report its operational and financial results for its fiscal 2025...
by lythamcorp | Apr 7, 2025 | Healthcare, ImmuCell Corporation, ImmuCell News
PORTLAND, Maine, April 07, 2025 — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the...